In patients with advanced MTC, a notable increase in CEA disproportionate to low serum calcitonin levels, but also the finding of normal or low CEA and calcitonin levels indicate poorly differentiated MTC [21]. This evidence concerns the gene CEACAM5 and medullary thyroid gland carcinoma.